Publication | Open Access

Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist

NeurophysiologyCombined AdministrationParkinson DiseaseMedicineNeuropharmacologyA2a Receptor AntagonistNeurologyNeuroscienceCentral Nervous SystemNervous SystemDopaminePharmacologyNeurochemistrySocial Sciences6-Hydroxydopamine-lesioned Rat Model